Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

01-07-2006 | Original Paper

Hyperserotoninemia and Altered Immunity in Autism

Auteurs: Nancy K. Burgess, Thayne L. Sweeten, William M. McMahon, Robert S. Fujinami

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 5/2006

Abstract

One of the most consistent biological findings in autism is elevated whole blood serotonin (5-HT) levels found in about 1/3 of cases. Immune abnormalities are also commonly observed in this disorder. Given 5-HT’s role as an immunomodulator, possible connections between 5-HT and immune abnormalities in autism are explored in this review. Areas of focus include hyperserotoninemia and cellular immune function, autoantibodies to 5-HT receptors, and 5-HT’s role in autoimmunity. Further research is needed to determine the interactions between neuropsychiatric and immune dysfunction in autism and related disorders.

vorige artikel The Impact of Child Symptom Severity on Depressed Mood Among Parents of Children with ASD: The Mediating Role of Stress Proliferation

volgende artikel A Case of Partial Trisomy of Chromosome 8p Associated with Autism

Abramson, R. K., Self, S., Genco, P., Smith, N., Pendleton, A., Valentine, J., Wright, H. H., Cuccaro, M., & Powell, D. (1990). The relationship between lymphocyte cell surface markers and serotonin in autistic probands. American Journal of Human Genetics, 47, A45.

Ameisen, J. C., Meade, R., & Askenase, P. W. (1989). A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells. Journal of Immunology, 142, 3171–3179.

Anderson, G. M., Feibel, F. C., & Cohen, D. J. (1987a). Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Life Science, 40, 1063–1070. CrossRef

Anderson, G. M., Freedman, D. X., Cohen, D. J., Volkmar, F. R., Hoder, E. L., McPhedran, P., Minderaa, R. B., Hansen, C. R., & Young, J. G. (1987b). Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry, 28, 885–900. CrossRef

Anderson, G. M., Gutknecht, L., Cohen, D. J., Brailly-Tabard, S., Cohen, J. H., Ferrari, P., Roubertoux, P. L., & Tordjman, S. (2002). Serotonin transporter promoter variants in autism: Functional effects and relationship to platelet hyperserotonemia. Molecular Psychiatry, 7, 831–836. CrossRefPubMed

Askenase, P. W., Herzog, W. R., Millet, I., Paliwal, V., Ramabhadran, R., Rochester, C., Geba, G. P., & Ptak, W. (1991). Serotonin initiation of delayed-type hypersensitivity: mediation by a primitive Thy-1+ antigen-specific clone or by specific monoclonal IgE antibody. Skin Pharmacol, 4(Suppl 1), 25–42. PubMedCrossRef

Aune, T. M., Golden, H. W., McGrath, K. M. (1994). Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. Journal of Immunology, 153, 489–498.

Aune, T. M., McGrath, K. M., Sarr, T., Bombara, M. P. & Kelley, K. A. (1993). Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. Journal of Immunology, 151, 1175–1183.

Betancur, C., Corbex, M., Spielewoy, C., Philippe, A., Laplanche, J. L., Launay, J. M., Gillberg, C., Mouren-Simeoni, M. C., Hamon, M., Giros, B., Nosten-Bertrand, M., & Leboyer, M. (2002). Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Molecular Psychiatry, 7, 67–71. CrossRefPubMed

Black, C., Kaye, J. A., & Jick, H. (2002). Relation of childhood gastrointestinal disorders to autism: Nested case-control study using data from the UK General Practice Research Database. BMJ, 325, 419–421. CrossRefPubMed

Bonnet, M., Lespinats, G., & Burtin, C. (1984). Histamine and serotonin suppression of lymphocyte response to phytohemagglutinin and allogeneic cells. Cell Immunology, 83, 280–291. CrossRef

Chess, S., (1971). Autism in children with congenital rubella. Journal of Autism and Childhood Schizophrenia, 1, 33–47. CrossRefPubMed

Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., & Chugani, H. T. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287–295. CrossRefPubMed

Chugani, D. C., Muzik, O., Rothermel, R., Behen, M., Chakraborty, P., Mangner, T., da Silva, E. A., & Chugani, H. T. (1997). Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Annals of Neurology, 42, 666–669. CrossRefPubMed

Cohen, D. J., Shaywitz, B. A., Johnson, W. T., & Bowers, M., Jr. (1974). Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid. Archives of General Psychiatry, 31, 845–853.

Comi, A. M., Zimmerman, A. W., Frye, V. H., Law, P. A., & Peeden, J. N. (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. Journal of Child Neurology, 14, 388–394. PubMedCrossRef

Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., & Deuel, R. K. (1999). Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. Journal of Pediatrics, 134, 607–613. CrossRefPubMed

Cook, E. H., Jr., Arora, R. C., Anderson, G. M., Berry-Kravis, E. M., Yan, S. Y., Yeoh, H. C., Sklena, P. J., Charak, D. A., & Leventhal, B. L. (1993a). Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Science, 52, 2005–2015.

Cook, E. H., Jr., Courchesne, R., Lord, C., Cox, N. J., Yan, S., Lincoln, A., Haas, R., Courchesne, E., & Leventhal, B. L. (1997). Evidence of linkage between the serotonin transporter and autistic disorder. Molecular Psychiatry, 2, 247–250.

Cook, E. H., Jr., Leventhal, B. L., & Freedman, D. X. (1988). Free serotonin in plasma: Autistic children and their first-degree relatives. Biological Psychiatry, 24, 488–491.

Cook, E. H., Jr., Leventhal, B. L., Heller, W., Metz, J., Wainwright, M., & Freedman, D. X. (1990). Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. Journal of Neuropsychiatry and Clinical Neurosciences, 2, 268–274.

Cook, E. H., Jr., Perry, B. D., Dawson, G., Wainwright, M. S., & Leventhal, B. L. (1993b). Receptor inhibition by immunoglobulins: Specific inhibition by autistic children, their relatives, and control subjects. Journal of Autism and Developmental Disorders, 23, 67–78.

Courchesne, E., Carper, R., & Akshoomoff, N. (2003). Evidence of brain overgrowth in the first year of life in autism. JAMA, 290, 337–344. CrossRefPubMed

Croonenberghs, J., Delmeire, L., Verkerk, R., Lin, A. H., Meskal, A., Neels, H., Van der, P. M., Scharpe, S., Deboutte, D., Pison, G., & Maes, M. (2000). Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology, 22, 275–283.

Curin, J. M., Terzic, J., Petkovic, Z. B., Zekan, L., Terzic, I. M., & Susnjara, I. M. (2003). Lower cortisol and higher ACTH levels in individuals with autism. Journal of Autism and Developmental Disorders, 33, 443–448. CrossRefPubMed

DeFelice, M. L., Ruchelli, E. D., Markowitz, J. E., Strogatz, M., Reddy, K. P., Kadivar, K., Mulberg, A. E., & Brown, K. A. (2003). Intestinal cytokines in children with pervasive developmental disorders. American Journal of Gastroenterology, 98, 1777–1782. CrossRefPubMed

DelGiudice-Asch, G., & Hollander, E. (1997). Altered immune function in autism. CNS Spectrums, 2, 61–67.

Denney, D. R., Frei, B. W., & Gaffney, G. R. (1996). Lymphocyte subsets and interleukin-2 receptors in autistic children. Journal of Autism and Developmental Disorders, 26, 87–97. CrossRefPubMed

Dietsch, G. N., & Hinrichs, D. J. (1989). The role of mast cells in the elicitation of experimental allergic encephalomyelitis. Journal of Immunology, 142, 1476–1481.

Folstein, S., & Rutter, M. (1977). Infantile autism: A genetic study of 21 twin pairs. Journal of Child Psychology and Psychiatry, 18, 297–321. PubMedCrossRef

Foon, K. A., Wahl, S. M., Oppenheim, J. J., & Rosenstreich, D. L. (1976). Serotonin-induced production of a monocyte chemotactic factor by human peripheral blood leukocytes. Journal of Immunology, 117, 1545–1552.

Gabrilovac, J., Cicin-Sain, L., Osmak, M., & Jernej, B. (1992). Alteration of NK- and ADCC-activities in rats genetically selected for low or high platelet serotonin level. Journal of Neuroimmunology, 37, 213–222. CrossRefPubMed

Geba, G. P., Ptak, W., Anderson, G. M., Paliwal, V., Ratzlaff, R. E., Levin, J., & Askenase, P. W. (1996). Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of contact sensitivity. Journal of Immunology, 157, 557–565.

Gillberg, C., Svennerholm, L., & Hamilton-Hellberg, C. (1983). Childhood psychosis and monoamine metabolites in spinal fluid. Journal of Autism and Developmental Disorders, 13, 383–396. CrossRefPubMed

Gray, R. S., McCorkle, F. M., Denno, K. M., & Taylor, R. L., Jr. (1991). Modulation of chicken plaque-forming cells by serotonin and dopamine. Poultry Science, 70, 1521–1526.

Hanley, H. G., Stahl, S. M., & Freedman, D. X. (1977). Hyperserotonemia and amine metabolites in autistic and retarded children. Archives of General Psychiatry, 34, 521–531. PubMed

Hellstrand, K., Czerkinsky, C., Ricksten, A., Jansson, B., Asea, A., Kylefjord, H., & Hermodsson, S. (1993). Role of serotonin in the regulation of interferon-gamma production by human natural killer cells. Journal of Interferon Research, 13, 33–38. PubMed

Hellstrand, K., & Hermodsson, S. (1987). Role of serotonin in the regulation of human natural killer cell cytotoxicity. Journal of Immunology, 139, 869–875.

Hellstrand, K., & Hermodsson, S. (1990). Enhancement of human natural killer cell cytotoxicity by serotonin: Role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors. Cell Immunology, 127, 199–214. CrossRef

Henson, P. M., & Spiegelberg, H. L. (1973). Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses. Journal of Clinical Investigation, 52, 1282–1288. PubMedCrossRef

Hérault, J., Petit, E., Martineau, J., Cherpi, C., Perrot, A., Barthélémy, C., Lelord, G., & Müh, J. P. (1996). Serotonin and autism: Biochemical and molecular biology features. Psychiatry Research, 65, 33–43. CrossRefPubMed

Horvath, K., Papadimitriou, J. C., Rabsztyn, A., Drachenberg, C., & Tildon, J. T. (1999). Gastrointestinal abnormalities in children with autistic disorder. Journal of Pediatrics, 135, 559–563. CrossRefPubMed

Huh, G. S., Boulanger, L. M., Du, H., Riquelme, P. A., Brotz, T. M., & Shatz, C. J. (2000). Functional requirement for class I MHC in CNS development and plasticity. Science, 290, 2155–2159. CrossRefPubMed

Jackson, J. C., Cross, R. J., Walker, R. F., Markesbery, W. R., Brooks, W. H., & Roszman, T. L. (1985). Influence of serotonin on the immune response. Immunology, 54, 505–512. PubMed

Jackson, J. C., Walker, R. F., Brooks, W. H., & Roszman, T. L. (1988). Specific uptake of serotonin by murine macrophages. Life Science, 42, 1641–1650. CrossRef

Kemper, T. L., Bauman, M. (1998). Neuropathology of infantile autism. Journal of Neuropathology and Experimental Neurology, 57, 645–652. PubMedCrossRef

Khan, N.-A., & Poisson, J.-P. (1999). 5-HT3 receptor-channels coupled with Na⁺ influx in human T cells: Role in T cell activation. Journal of Neuroimmunology, 99, 53–60. CrossRefPubMed

Klareskog, L., Forsum, U., Scheynius, A., Kabelitz, D., & Wigzell, H. (1982). Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the USA, 79, 3632–3636. PubMedCrossRef

Klauck, S. M., Poustka, F., Benner, A., Lesch, K. P., & Poustka, A. (1997). Serotonin transporter (5-HTT) gene variants associated with autism? Human Molecular Genetics, 6, 2233–2238. CrossRefPubMed

Kuperman, S., Beeghly, J. H., Burns, T. L., & Tsai, L. Y. (1985). Serotonin relationships of autistic probands and their first-degree relatives. Journal of the American Academy of Child and Adolescent Psychiatry, 24, 186–190. CrossRef

Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Muller, C. R., Hamer, D. H., & Murphy, D. L. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274, 1527–1531. CrossRefPubMed

Linden, D. R., Chen, J.-X., Gershon, M. D., Sharkey, K. A., & Mawe, G. M. (2003). Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 285, G207–G216. PubMed

Maestrini, E., Lai, C., Marlow, A., Matthews, N., Wallace, S., Bailey, A., Cook, E. H., Jr., Weeks, D. E., & Monaco, A. P. (1999). Serotonin transporter (5-HTT) and γ-aminobutyric acid receptor subunit β3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. American Journal of Medical Genetics, 88, 492–496.

Marchetti, B., Scifo, R., Batticane, N., & Scapagnini, U. (1990). Immunological significance of opioid peptide dysfunction in infantile autism. Brain Dysfunction, 3, 346–354.

Mårtensson, U., & Nässberger, L. (1993). Influence of antidepressants on mitogen stimulation of human lymphocytes. Toxic in Vitro, 7, 241–245. CrossRef

McBride, P. A., Anderson, G. M., Hertzig, M. E., Snow, M. E., Thompson, S. M., Khait, V. D., Shapiro, T., & Cohen, D. J. (1998). Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 767–776. CrossRefPubMed

McBride, P. A., Anderson, G. M., Hertzig, M. E., Sweeney, J. A., Kream, J., Cohen, D. J., & Mann, J. J. (1989). Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Archives of General Psychiatry, 46, 213–221. PubMed

McDougle, C. J., Holmes, J. P., Carlson, D. C., Pelton, G. H., Cohen, D. J., & Price, L. H. (1998). A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Archives of General Psychiatry, 55, 633–641. CrossRefPubMed

McDougle, C. J., Naylor, S. T., Cohen, D. J., Aghajanian, G. K., Heninger, G. R., & Price, L. H. (1996a). Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry, 53, 993–1000.

McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996b). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001–1008.

Ménage, P., Thibault, G., Barthélémy, C., Lelord, G., & Bardos, P. (1992). CD4⁺ CD45RA⁺T lymphocyte deficiency in autistic children: Effect of a pyridoxine-magnesium treatment. Brain Dysfunction, 5, 326–333.

Minderaa, R. B., Anderson, G. M., Volkmar, F. R., Akkerhuis, G. W., & Cohen, D. J. (1987). Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects. Biological Psychiatry, 22, 933–940. CrossRefPubMed

Money, J., Bobrow, N. A., & Clarke, F. C. (1971). Autism and autoimmune disease: A family study. Journal of Autism and Childhood Schizophrenia, 1, 146–160. CrossRefPubMed

Mössner, R., & Lesch, K.-P. (1998). Role of serotonin in the immune system and in neuroimmune interactions. Brain Behavior and Immunity, 12, 249–271. CrossRef

Mulder, E. J., Anderson, G. M., Kema, I. P., de Bildt, A., van Lang, N. D., den Boer, J. A., Minderaa, R. B. (2004). Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 491–499. CrossRefPubMed

Paegelow, I., Werner, H., Hagen, M., Wartner, U., & Lange, P. (1985). Influence of serotonin on lymphokine secretion in vitro. International Journal of Immunopharmacology, 7, 889–896. CrossRefPubMed

Perry, B. D., Cook, E. H., Jr., Leventhal, B. L., Wainwright, M. S., & Freedman, D. X. (1991). Platelet 5-HT2 serotonin receptor binding sites in autistic children and their first-degree relatives. Biological Psychiatry, 30, 121–130.

Persico, A. M., Militerni, R., Bravaccio, C., Schneider, C., Melmed, R., Conciatori, M., Damiani, V., Baldi, A., & Keller, F. (2000). Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples. American Journal of Medical Genetics, 96, 123–127. CrossRefPubMed

Plioplys, A. V. (1998). Intravenous immunoglobulin treatment of children with autism. Journal of Child Neurology, 13, 79–82. PubMedCrossRef

Plioplys, A. V., Greaves, A., Kazemi, K., & Silverman, E. (1994). Lymphocyte function in autism and Rett syndrome. Neuropsychobiology, 29, 12–16. PubMedCrossRef

Poljak-Blazi, M., Jernej, B., Cicin-Sain, L., Boranic, M. (1990). Immunological response of rats selected for high or low platelet serotonin content. Periodicum Biologorum, 92, 189–190.

Rogers, T., Kalaydjieva, L., Hallmayer, J., Petersen, P. B., Nicholas, P., Pingree, C., McMahon, W. M., Spiker, D., Lotspeich, L., Kraemer, H., McCague, P., Dimiceli, S., Nouri, N., Peachy, T., Yang, J., Hinds, D., Risch, N., & Myers, R.M. (1999). Exclusion of linkage to the HLA region in ninety multiplex sibships with autism. Journal of Autism and Developmental Disorders, 29, 195–201. CrossRefPubMed

Schain, R. J., & Freedman, D. X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. Journal of Pediatrics, 58, 315–320. PubMedCrossRef

Scifo, R., Cioni, M., Nicolosi, A., Batticane, N., Tirolo, C., Testa, N., Quattropani, M. C., Morale, M. C., Gallo, F., & Marchetti, B. (1996). Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. Annali dell’Istituo Superiore di Sanita, 32, 351–359.

Singh, V. K., & Rivas, W. H. (2004). Prevalence of serum antibodies to caudate nucleus in autistic children. Neuroscience Letters, 355, 53–56. CrossRefPubMed

Singh, V. K., Singh, E. A., & Warren, R. P. (1997). Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Biological Psychiatry, 41, 753–755. CrossRefPubMed

Singh, V. K., Warren, R. P., Odell, J. D., Warren, W. L., & Cole, P. (1993). Antibodies to myelin basic protein in children with autistic behavior. Brain Behavior and Immunity, 7, 97–103. CrossRef

Singh, V. K., Warren, R. P., & Singh, E. A. (1990). Binding of ³H serotonin to lymphocytes in patients with neuropsychiatric disorders. Molecular and Chemical Neuropathology, 13, 167–173. PubMedCrossRef

Slauson, D. O., Walker, C., Kristensen, F., Wang, Y., & de Weck, A. L. (1984). Mechanisms of serotonin-induced lymphocyte proliferation inhibition. Cell Immunology, 84, 240–252. CrossRef

Sternberg, E. M., Trial, J., & Parker, C. W. (1986). Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. Journal of Immunology, 137, 276–282.

Stubbs, E.G. (1978). Autistic symptoms in a child with congenital cytomegalovirus infection. Journal of Autism and Childhood Schizophrenia, 8, 37–43. CrossRefPubMed

Stubbs, E. G., Crawford, M. L., Burger, D. R., Vandenbark, A. A. (1977). Depressed lymphocyte responsiveness in autistic children. Journal of Autism and Childhood Schizophrenia, 7, 49–55. CrossRefPubMed

Sweeten, T. L., Bowyer, S. L., Posey, D. J., Halberstadt, G. M., & McDougle, C. J. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics, 112, e420. CrossRefPubMed

Sweeten, T. L., Posey, D. J., & McDougle, C. J. (2004). Autistic disorder in three children with cytomegalovirus infection. Journal of Autism and Developmental Disorders, 34, 583–586. CrossRefPubMed

Sweeten, T. L., Posey, D. J., Shekhar, A., & McDougle, C. J. (2002). The amygdala and related structures in the pathophysiology of autism. Pharmacology Biochemistry and Behavior, 71, 449–455. CrossRef

Todd, R. D., & Ciaranello, R. D. (1985). Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proceedings of the National Academy of Sciences of the USA, 82, 612–616. PubMedCrossRef

Torres, A. R., Maciulis, A., Stubbs, E. G., Cutler, A., & Odell, D. (2002). The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Human Immunology, 63, 311–316. CrossRefPubMed

van Gent, T., Heijnen, C. J., & Treffers, P. D. (1997). Autism and the immune system. Journal of Child Psychology and Psychiatry, 38, 337–349. PubMedCrossRef

Veenstra-VanderWeele, J., Kim, S. J., Lord, C., Courchesne, R., Akshoomoff, N., Leventhal, B. L., Courchesne, E., & Cook, E. H., Jr. (2002). Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism. American Journal of Medical Genetics, 114, 277–283.

Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., Montgomery, S. M., Davies, S., O’Leary, J. J., Berelowitz, M., & Walker-Smith, J. A. (2000). Enterocolitis in children with developmental disorders. American Journal Gastroenterology, 95, 2285–2295. CrossRef

Walther, D. J., Peter, J. U., Bashammakh, S., Hortnagl, H., Voits, M., Fink, H., & Bader, M. (2003). Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science, 299, 76. CrossRefPubMed

Warren, R. P., Foster A. & Margaretten, N. C. (1987). Reduced natural killer cell activity in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 333–335PubMedCrossRef

Warren, R. P., Kane, K. K., Burger, R. A., Singh, V. K. (1990). Serotonin-induced suppression of lymphocyte DNA synthesis and natural killer cell activity. Annals of the New York Academy of Sciences, 594, 429–431. CrossRef

Warren, R. P., Margaretten, N. C., Pace, N. C., & Foster, A. (1986). Immune abnormalities in patients with autism. Journal of Autism and Developmental Disorders, 16, 189–197. CrossRefPubMed

Warren, R. P., & Singh, V. K. (1996). Elevated serotonin levels in autism: Association with the major histocompatibility complex. Neuropsychobiology, 34, 72–75. PubMedCrossRef

Warren, R. P., Singh, V. K., Cole, P., Odell, J. D., Pingree, C. B., Warren, W. L., DeWitt, C. W., & McCullough, M. (1992). Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics, 36, 203–207. CrossRefPubMed

Warren, R. P., Yonk, J., Burger, R. W., Odell, D., & Warren, W. L. (1995). DR-positive T cells in autism: Association with decreased plasma levels of the complement C4B protein. Neuropsychobiology, 31, 53–57. PubMedCrossRef

Yirmiya, N., Pilowsky, T., Nemanov, L., Arbelle, S., Feinsilver, T., Fried, I., Ebstein, R. P. (2001). Evidence for an association with the serotonin transporter promoter region polymorphism and autism. American Journal of Medical Genetics, 105, 381–386. CrossRefPubMed

Young, M. R. I., Kut, J. L., Coogan, M. P., Wright, M. A., Young, M. E., & Matthews, J. (1993). Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology, 80, 395–400. PubMed

Yuwiler, A., Shih, J. C., Chen, C. H., Ritvo, E. R., Hanna, G., Ellison, G. W., & King, B. H. (1992). Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. Journal of Autism and Developmental Disorders, 22, 33–45. CrossRefPubMed

Zhong, N., Ye, L., Ju, W., Brown, W. T., Tsiouris, J., & Cohen, I. (1999). 5-HTTLPR variants not associated with autistic spectrum disorders. Neurogenetics, 2, 129–131. CrossRefPubMed

Titel: Hyperserotoninemia and Altered Immunity in Autism
Auteurs: Nancy K. Burgess
Thayne L. Sweeten
William M. McMahon
Robert S. Fujinami
Publicatiedatum: 01-07-2006
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 5/2006
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-006-0100-7

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 5/2006

Discrimination in Autism Within Different Sensory Modalities

Physical Activity Patterns in Youth with Autism Spectrum Disorders

An MRI Study of Minor Physical Anomalies in Autism

Superior Disembedding Performance of High-Functioning Individuals with Autism Spectrum Disorders and Their Parents: The Need for Subtle Measures

Sleep Patterns of School-Age Children with Asperger Syndrome or High-Functioning Autism

The Collateral Effects of Joint Attention Training on Social Initiations, Positive Affect, Imitation, and Spontaneous Speech for Young Children with Autism